secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0000883984-24-000040
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q3 2024 revenue up 6.5% to $589.1M; GAAP net loss $33M, adj EPS $1.59
--------------------------------------------------------------------------------

- Revenue $589.1M vs $553.3M YoY; GAAP gross margin improved to 34.8% from 33.2%.
- GAAP net loss $(33.0)M ($1.35 per diluted share) vs net income $7.2M ($0.30) in Q3 2023.
- Adjusted diluted EPS $1.59 vs $1.57 YoY; Adjusted EBITDA $94.8M vs $89.8M.
- Company updated FY2024 guidance; specific guidance numbers not fully disclosed in excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000040/0000883984-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000040/icui-20241112.htm
  HTML page:      https://secwatch.observer/filing/0000883984-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer